Clinical Trial Update: Self-Management Addressing Heart Disease Risk Trial [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating a self-management program to reduce heart disease risk in people with bipolar disorder; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder
• Cardiovascular Disease

Snippet

Sponsor: US Department of Veterans Affairs | Conditions: Bipolar Disorder, Cardiovascular Disease | Phase 3 | Status: COMPLETED | Results posted: 2014-11-20